IndicationsCrizotinib, also known as XALKORI, is indicated for the treatment of:ALK‑positive or ROS1‑positive metastatic non‑small cell lung cancer (N···【Read More】
Update: 2026-03-09Source: Haiou HealthViews: 71
Indications and Mechanism of ActionCrizotinib is indicated for patients with ALK‑positive locally advanced or metastatic non‑small cell lung cancer (N···【Read More】
Update: 2026-03-09Source: Haiou HealthViews: 72
FDA Approval AnnouncementYesterday, the U.S. Food and Drug Administration (FDA) approved an extended duration of use for Prevymis (letermovir), from 1···【Read More】
Update: 2026-03-09Source: Haiou HealthViews: 72
FDA Approval AnnouncementAccording to a press release from Merck & Co., Inc. dated June 6, the U.S. Food and Drug Administration (FDA) has approve···【Read More】
Update: 2026-03-09Source: Haiou HealthViews: 72
Drug Interactions of Letermovir TabletsConcomitant Medications That Are Strictly ContraindicatedConcomitant use with the following drugs is strictly p···【Read More】
Update: 2026-03-09Source: Haiou HealthViews: 71
Mechanism of Action and Therapeutic EffectsLetermovir tablets are an antiviral medication with the active ingredient letermovir, specifically indicate···【Read More】
Update: 2026-03-09Source: Haiou HealthViews: 71
Entrectinib is a targeted therapy for NTRK gene fusion-positive solid tumors and ROS1-positive non-small cell lung cancer. Its price varies depending ···【Read More】
Update: 2026-03-09Source: Haiou HealthViews: 73
Crizotinib (Xalkori) is an oral kinase inhibitor that may be used to treat:1.Adults with non-small cell lung cancer which has spread to other parts of···【Read More】
Update: 2026-03-09Source: Haiou HealthViews: 76
Store at room temperature 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F).【Read More】
Update: 2026-03-09Source: Haiou HealthViews: 73
Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may incre···【Read More】
Update: 2026-03-09Source: Haiou HealthViews: 73
If a dose of crizotinib is missed, it should be taken as soon as you remember. If it is close to the time of the next dose (within 6 hours), the misse···【Read More】
Update: 2026-03-09Source: Haiou HealthViews: 73
Clinical Background of ALK-Positive NSCLCLung cancer is one of the leading causes of cancer-related death worldwide, accounting for the highest number···【Read More】
Update: 2026-03-09Source: Haiou HealthViews: 71
FDA Approval AnnouncementMarch 11, 2016 -- The U.S. Food and Drug Administration (FDA) approved Xalkori (crizotinib) for the treatment of patients wit···【Read More】
Update: 2026-03-09Source: Haiou HealthViews: 71
FDA Approval AnnouncementNEW YORK--(BUSINESS WIRE) January 14, 2021 -- Pfizer Inc. (NYSE:PFE) announced that the U.S. Food and Drug Administration (FD···【Read More】
Update: 2026-03-09Source: Haiou HealthViews: 73
FDA Approval AnnouncementOn July 14, 2022, the U.S. Food and Drug Administration (FDA) approved crizotinib (Xalkori, Pfizer Inc.) for adult and pediat···【Read More】
Update: 2026-03-09Source: Haiou HealthViews: 72
Copyright2024@ BIGBEAR All right reserved BIGBEAR



